Using ultra-high performance liquid chromatography coupled with tandem mass spectrometry (UHPLC-MS/MS), a Polish research team discovered interesting new insights into the changes in sphingolipid metabolism in patients with early-stage primary biliary cholangitis (PBC). The findings encourage further research into the potential benefits of sphingolipids as biomarkers and targets in cholestatic liver diseases, the authors conclude.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- From symptom to diagnosis
Abdominal pain – Sprue
- Case Report
76-year-old patient with pustular skin rash
- Sponsored Content: Psoriasis
Dauerhafte Erscheinungsfreiheit auch bei betroffenen speziellen Hautarealen
- Antithymocyte globulin in children with T1D
Old medicine, new hope
- Ginkgo biloba
Database of preclinical and clinical studies is becoming increasingly larger
- Digital biomarkers
Continuous monitoring using digital biomarkers in MS care
- Benefits, limits and safety aspects
Phytotherapy for cardiovascular diseases
- Results of the FOREST HCM study